'Now you are going overboard': After Bombay high court rap, FDA withdraws order cancelling licence of Cipla Pharma
The Food and Drug Administration (FDA) withdrew its order cancelling Cipla Pharma's drug sale licenses after the Bombay High Court criticized the FDA's actions. The court found the FDA's decision violated principles of natural justice, noting no safety or quality concerns were raised. Cipla is now set to receive a fresh show cause notice regarding the matter.